Clinical and pathological features of Parkinson's disease

SA Schneider, JA Obeso - Behavioral Neurobiology of Huntington's …, 2015 - Springer
SA Schneider, JA Obeso
Behavioral Neurobiology of Huntington's disease and Parkinson's disease, 2015Springer
Parkinson's disease (PD) is, after Alzheimer's disease, the second most common
neurodegenerative disorder with an approximate prevalence of 0.5–1% among persons 65–
69 years of age, rising to 1–3% among persons 80 years of age and older. Pathologically,
PD is characterized by the loss of neurons in the substantia nigra pars compacta (SNpc),
and by the presence of eosinophilic protein deposits (Lewy bodies) in this region, in other
aminergic nuclei and in cortical and limbic structures. Moreover, it has now been shown that …
Abstract
Parkinson’s disease (PD) is, after Alzheimer’s disease, the second most common neurodegenerative disorder with an approximate prevalence of 0.5–1 % among persons 65–69 years of age, rising to 1–3 % among persons 80 years of age and older. Pathologically, PD is characterized by the loss of neurons in the substantia nigra pars compacta (SNpc), and by the presence of eosinophilic protein deposits (Lewy bodies) in this region, in other aminergic nuclei and in cortical and limbic structures. Moreover, it has now been shown that pathology also involves the peripheral nervous system. Braak and colleagues suggested a thread of pathology starting from the vagal nerve to progress to the brainstem, and eventually to limbic and neocortical brain regions. This progression of pathology may account for the clinical evolution of PD toward a composite symptomatology. However, this hypothesis has been criticized by others. In this chapter, we review the clinical features of PD (motor and nonmotor) and their pathological correlates.
Springer